Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H24O2 |
Molecular Weight | 296.4034 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C=C(O)C=C4
InChI
InChIKey=BFPYWIDHMRZLRN-SLHNCBLASA-N
InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1
Molecular Formula | C20H24O2 |
Molecular Weight | 296.4034 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:20 UTC 2023
by
admin
on
Fri Dec 15 15:20:20 UTC 2023
|
Record UNII |
423D2T571U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QG03AA06
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
NDF-RT |
N0000000100
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
18.3.1 (ETH/LEV)
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB03
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA02
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB05
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA07
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA13
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB07
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA10
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB01
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03CA01
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA07
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QL02AA03
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
NDF-RT |
N0000175825
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA03
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA15
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA04
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
18.3.1 (ETH/NOR)
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB01
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
NCI_THESAURUS |
C478
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA12
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA16
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA12
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA05
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA08
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA04
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03CA01
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB04
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB06
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA05
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA01
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA09
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA06
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA10
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB03
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA02
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
FDA ORPHAN DRUG |
28788
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA08
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB05
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB07
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
LIVERTOX |
382
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB04
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA11
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA13
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA16
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA15
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA03
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA09
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB02
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AA01
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AB06
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EVRA (AUTHORIZED: CONTRACEPTION)
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-VATC |
QG03AA11
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
G03AB02
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
||
|
WHO-ATC |
L02AA03
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB07277MIG
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
423D2T571U
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
423D2T571U
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
5991
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
1260001
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
C486
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
ETHINYL ESTRADIOL
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | Description: A white to slightly yellowish white, crystalline powder; odourless.Solubility: Practically insoluble in water; freely soluble in ethanol (~750 g/l) TS; soluble in acetone R and dioxan R.Category: Estrogen.Storage: Ethinylestradiol should be kept in a well-closed container, protected from light.Additional information: Ethinylestradiol may exist in 2 polymorphic forms one of which melts at about 183?C, the other, metastable, at about 143?C.RequirementsDefinition: Ethinylestradiol contains not less than 97.0% and not more than 102.0% of C20H24O2, calculated with reference to the dried substance. | ||
|
4903
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
10973
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
100000091721
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
CHEMBL691
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
DB00977
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
m5058
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | Merck Index | ||
|
D004997
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
Ethinyl Estradiol
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
DTXSID5020576
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
200-342-2
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
4124
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | RxNorm | ||
|
437
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
7071
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
1082
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
57-63-6
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
3587
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY | |||
|
ETHINYL ESTRADIOL
Created by
admin on Fri Dec 15 15:20:20 UTC 2023 , Edited by admin on Fri Dec 15 15:20:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
DERIVATIVE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MAJOR
PLASMA
|
||
|
PRODRUG -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |